BioCentury | Sep 10, 2020
Product Development

Having touched the third rail of data sharing in the pandemic, drug developers should hold on tight

...COVID-19 Resource Center). Working through member company Evotec SE...
BioCentury | Aug 21, 2020
Deals

Aug. 20 Quick Takes: Funding for Alzheon’s Alzheimer’s Phase III; plus Merck, FDA guidance, LumiraDx, RACE for Children, blood plasma and Novo-Evotec

...Institute of Allergy and Infectious Diseases did not respond to a request for comment from BioCentury.Evotec...
...discovery and preclinical development, after which Novo will be responsible for clinical development and commercialization. Evotec...
...Apolipoprotein E epsilon 4 Paul Bonanos ALZ-801, blu8499, NRM8499, NRM-8499 Keytruda, pembrolizumab (MK-3475, lambrolizumab) Alzheon Inc. Merck & Co. Inc. LumiraDx Ltd. NIH Evotec SE Novo...
BioCentury | Aug 14, 2020
Deals

Data Bytes: Bayer building women’s health portfolio

...NASDAQ:DARE) for an option to commercialize its hormone-free vaginal contraceptive Ovaprene in the U.S.; and with Evotec SE...
BioCentury | Aug 14, 2020
Finance

OSI leverages foundational deal with Oxford to build its life sciences portfolio

...Lab282, a joint partnership between the university, tech transfer office Oxford University Innovation, OSI and Evotec SE...
BioCentury | Aug 6, 2020
Product Development

Aug. 5 Quick Takes: Strong quarterly sales of Horizon’s Tepezza, Global Blood’s Oxbryta; plus a setback for DBV and news from Point, Karuna, Evotec-Secarna, Red

...a Phase III trial in schizophrenia planned for this year. Evotec partners with ASO-focused Secarna Evotec...
...SAR164877) DBV Technologies S.A. Point Biopharma Inc. Karuna Therapeutics Inc. Redx Pharma plc AstraZeneca plc Zai Lab Ltd. Deciphera Pharmaceuticals Inc. Secarna Pharmaceuticals GmbH Evotec...
BioCentury | Jul 23, 2020
Deals

July 22 Quick Takes: BioNTech raises $512M; plus Vesigen, Quantro, Cullinan, TransThera, JW-Syracuse, AnHeart-NewG

...BI, Evotec Quantro Therapeutics GmbH raised an undisclosed seed round from Boehringer Ingelheim GmbH and Evotec...
BioCentury | Jun 27, 2020
Product Development

Modeling harmony: learning from preclinical coordination of COVID-19 countermeasures

...but it’ll be a waste of money to invest in non-replicatable and non-industrializable data,” said Evotec SE...
...outbreak, and ideally to drug development more broadly. “This goes way beyond COVID-19.” Werner Lanthaler, Evotec...
...these aspects of the disease, relevant natural histories and molecular targets are still unclear, said Evotec...
BioCentury | Jun 25, 2020
Finance

Autobahn Labs bringing industrial translation to academic projects via joint ownership model, starting with UCLA

...to industrialize academic projects deemed too early for traditional tech transfer by running them through Evotec’s...
...goal of creating jointly owned spinouts backed by Autobahn’s investors. Launched Wednesday by Samsara Biocapital, Evotec SE...
...progressively meets go/no-go criteria in biological validation experiments, high-throughput screens and lead optimization studies by Evotec...
BioCentury | May 28, 2020
Finance

May 27 Quick Takes: Atara raises $176M on back of MS data; plus Exscientia’s $60M C round, Geron, Silence, Arvelle, ViaCyte, Poxel, Accure, Tollys

...in series C led by new investor Novo Holdings A/S, with participation from existing investors Evotec...
BioCentury | May 26, 2020
Product Development

Understanding and weaponizing immune responses to COVID-19

...Accelerator, and involves CROs Carterra LSA, Nexelis and the Just - Evotec Biologics unit of Evotec SE...
Items per page:
1 - 10 of 864
BioCentury | Sep 10, 2020
Product Development

Having touched the third rail of data sharing in the pandemic, drug developers should hold on tight

...COVID-19 Resource Center). Working through member company Evotec SE...
BioCentury | Aug 21, 2020
Deals

Aug. 20 Quick Takes: Funding for Alzheon’s Alzheimer’s Phase III; plus Merck, FDA guidance, LumiraDx, RACE for Children, blood plasma and Novo-Evotec

...Institute of Allergy and Infectious Diseases did not respond to a request for comment from BioCentury.Evotec...
...discovery and preclinical development, after which Novo will be responsible for clinical development and commercialization. Evotec...
...Apolipoprotein E epsilon 4 Paul Bonanos ALZ-801, blu8499, NRM8499, NRM-8499 Keytruda, pembrolizumab (MK-3475, lambrolizumab) Alzheon Inc. Merck & Co. Inc. LumiraDx Ltd. NIH Evotec SE Novo...
BioCentury | Aug 14, 2020
Deals

Data Bytes: Bayer building women’s health portfolio

...NASDAQ:DARE) for an option to commercialize its hormone-free vaginal contraceptive Ovaprene in the U.S.; and with Evotec SE...
BioCentury | Aug 14, 2020
Finance

OSI leverages foundational deal with Oxford to build its life sciences portfolio

...Lab282, a joint partnership between the university, tech transfer office Oxford University Innovation, OSI and Evotec SE...
BioCentury | Aug 6, 2020
Product Development

Aug. 5 Quick Takes: Strong quarterly sales of Horizon’s Tepezza, Global Blood’s Oxbryta; plus a setback for DBV and news from Point, Karuna, Evotec-Secarna, Red

...a Phase III trial in schizophrenia planned for this year. Evotec partners with ASO-focused Secarna Evotec...
...SAR164877) DBV Technologies S.A. Point Biopharma Inc. Karuna Therapeutics Inc. Redx Pharma plc AstraZeneca plc Zai Lab Ltd. Deciphera Pharmaceuticals Inc. Secarna Pharmaceuticals GmbH Evotec...
BioCentury | Jul 23, 2020
Deals

July 22 Quick Takes: BioNTech raises $512M; plus Vesigen, Quantro, Cullinan, TransThera, JW-Syracuse, AnHeart-NewG

...BI, Evotec Quantro Therapeutics GmbH raised an undisclosed seed round from Boehringer Ingelheim GmbH and Evotec...
BioCentury | Jun 27, 2020
Product Development

Modeling harmony: learning from preclinical coordination of COVID-19 countermeasures

...but it’ll be a waste of money to invest in non-replicatable and non-industrializable data,” said Evotec SE...
...outbreak, and ideally to drug development more broadly. “This goes way beyond COVID-19.” Werner Lanthaler, Evotec...
...these aspects of the disease, relevant natural histories and molecular targets are still unclear, said Evotec...
BioCentury | Jun 25, 2020
Finance

Autobahn Labs bringing industrial translation to academic projects via joint ownership model, starting with UCLA

...to industrialize academic projects deemed too early for traditional tech transfer by running them through Evotec’s...
...goal of creating jointly owned spinouts backed by Autobahn’s investors. Launched Wednesday by Samsara Biocapital, Evotec SE...
...progressively meets go/no-go criteria in biological validation experiments, high-throughput screens and lead optimization studies by Evotec...
BioCentury | May 28, 2020
Finance

May 27 Quick Takes: Atara raises $176M on back of MS data; plus Exscientia’s $60M C round, Geron, Silence, Arvelle, ViaCyte, Poxel, Accure, Tollys

...in series C led by new investor Novo Holdings A/S, with participation from existing investors Evotec...
BioCentury | May 26, 2020
Product Development

Understanding and weaponizing immune responses to COVID-19

...Accelerator, and involves CROs Carterra LSA, Nexelis and the Just - Evotec Biologics unit of Evotec SE...
Items per page:
1 - 10 of 864